February 7th, 2025 2:53 am
Read More...
Tags:
♫ Posted in Genetic Engineering | | Comments Off»
February 7th, 2025 2:53 am
Read More...
Tags:
♫ Posted in Genetic Engineering | | Comments Off»
February 7th, 2025 2:52 am
Market Closed - Nasdaq 04:00:00 2025-02-06 pm EST 5-day change 1st Jan Change 12.73 USD -1.55% -1.39% -7.15%
February 05, 2025 at 05:41 pm EST
To unlock the article, REGISTER!
DurationAuto.2 months3 months6 months9 months1 year2 years5 years10 yearsMax.
PeriodDayWeek
Last Close Price
12.73USD
Average target price
19.54USD
Spread / Average Target
+53.48%
+951% of historicalperformance
More than 20 yearsat your side
Our Expertsare here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
Stock quotes are provided by Factset, Morningstar and S&P Capital IQ
View post:
Myriad Genetics Get 2 Patents for Molecular Residual Disease Assay
Read More...
Tags:
♫ Posted in Molecular Genetics | | Comments Off»
February 7th, 2025 2:51 am
Read More...
Tags:
♫ Posted in Veterinary Medicine | | Comments Off»
February 7th, 2025 2:51 am
Read More...
Tags:
♫ Posted in Veterinary Medicine | | Comments Off»
February 7th, 2025 2:51 am
Read More...
Tags:
♫ Posted in Veterinary Medicine | | Comments Off»
February 7th, 2025 2:51 am
Read More...
Tags:
♫ Posted in Veterinary Medicine | | Comments Off»
February 7th, 2025 2:51 am
Read More...
Tags:
♫ Posted in Veterinary Medicine | | Comments Off»
February 7th, 2025 2:51 am
Read More...
Tags:
♫ Posted in Veterinary Medicine | | Comments Off»
February 7th, 2025 2:51 am
Read More...
Tags:
♫ Posted in Veterinary Medicine | | Comments Off»
February 7th, 2025 2:51 am
Read More...
Tags:
♫ Posted in Veterinary Medicine | | Comments Off»
February 7th, 2025 2:51 am
Read More...
Tags:
♫ Posted in Veterinary Medicine | | Comments Off»
February 7th, 2025 2:51 am
Read More...
Tags:
♫ Posted in Veterinary Medicine | | Comments Off»
February 7th, 2025 2:51 am
Read More...
Tags:
♫ Posted in Veterinary Medicine | | Comments Off»
February 7th, 2025 2:51 am
VANCOUVER, British Columbia, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing cancer therapies based on DNA-damage response technologies, announces continued advancement of its AI-driven drug discovery program. Over the next four months, additional small-molecule drug candidates, designed in collaboration with Pharma Inventor Inc., will be synthesized and delivered for further evaluation.
Continue reading here:
Rakovina Therapeutics Announces Additional Synthesized Compounds in its AI-Driven Cancer Drug Discovery Program
Read More...
Tags:
♫ Posted in Global News Feed | | Comments Off»
February 7th, 2025 2:51 am
WVE-007 is a novel, long-acting GalNAc-siRNA targeting INHBE mRNA – a genetically validated target that provides a new approach for healthy, sustainable weight loss (fat loss with muscle preservation)
See the original post here:
Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity
Read More...
Tags:
♫ Posted in Global News Feed | | Comments Off»
February 7th, 2025 2:51 am
Read More...
Tags:
♫ Posted in Global News Feed | | Comments Off»
February 7th, 2025 2:50 am
Harris, the Senior Vice President of Athlete Development and Marketing at the Ultimate Fighting Championship, has a distinguished career spanning over 40 years Harris, the Senior Vice President of Athlete Development and Marketing at the Ultimate Fighting Championship, has a distinguished career spanning over 40 years
Visit link:
BioAdaptives Welcomes UFC Senior Executive Reed Harris to Its Board of Advisors
Read More...
Tags:
♫ Posted in Global News Feed | | Comments Off»